Karleen Habin

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Xiao-Jun Ma, Zuncai Wang, Paula D. Ryan et al. · Cancer Cell · 2004 · 947 citations · Full text

Breast Oncology, Breast Cancer Patients, Medicine +9

A phase II trial of the PARP inhibitor veliparib (ABT888) and temozolomide for metastatic breast cancer.

SJ Isakoff, Beth Overmoyer, Nadine Tung et al. · Journal of Clinical Oncology · 2010 · 151 citations

Surgical Oncology, Breast Oncology, Pathology +16

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

Ben S. Wittner, Dennis C. Sgroi, Paula D. Ryan et al. · Clinical Cancer Research · 2008 · 145 citations · Full text

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes

Hadine Joffe, Ann Partridge, Anita Giobbie‐Hurder et al. · Menopause The Journal of The North American Menopause Society · 2010 · 50 citations

Comparison of tissue genotyping (TG) vs circulating tumor DNA (ctDNA) for selection of matched therapy and impact on clinical outcomes among patients with metastatic breast cancer (MBC).

Neelima Vidula, Dejan Juric, Andrzej Niemierko et al. · Journal of Clinical Oncology · 2018 · 40 citations

Breast Oncology, Cancer Pathology, Cancer Management +21